Statistics

MycoGenyx TM - Home

www.pharmamarketingltd.com/

Unser Mission Possible "Phagentherapie" ; Mission Possible ; EIN FÃ–RDERUNGSWÃœRDIGES, HUMANITÃ„RES FORSCHUNGSPROJET; BioPharmaForschungBakteriophagen ...

Pharmamarketingltd.com

Conversion Technology Metas Server

Pharmamarketingltd.com is hosted in Ireland / Dublin . Pharmamarketingltd.com doesn't use HTTPS protocol. Number of used technologies: 3. First technologies: CSS, Html, Javascript, Number of used javascripts: 1. First javascripts: Vp.js, Number of used analytics tools: 0. Its server type is: .

Technologies in use by Pharmamarketingltd.com

Technology

Number of occurences: 3

CSS
Html
Javascript

Javascripts

Number of occurences: 1

vp.js

Conversion rate optimization
Clickable call number	Not founded!
Conversion form (contact form, subcriber)	Not founded!
Clickable email	Not founded!
CTA (call to action) button	Not founded!
List	Not founded!
Image	Not founded!
Enhancement	Not founded!
Responsive website	Not founded!
Facebook sharing	Not founded!
Google+ sharing	Not founded!
Twitter sharing	Not founded!
Linkedin sharing	Not founded!
Blog on the webiste	Not founded!

HTTPS (SSL) - Pharmamarketingltd.com

Missing HTTPS protocol.

Meta - Pharmamarketingltd.com

Number of occurences: 3

Name: description
Content: Unser Mission Possible "Phagentherapie" ; Mission Possible ; EIN FÃ–RDERUNGSWÃœRDIGES, HUMANITÃ„RES FORSCHUNGSPROJET; BioPharmaForschungBakteriophagen Viridax; Pharma Marketing & PR Europe, Weltneuheit BioPharmaForschungBakteriophagen - Dortmund, Bakteriophagenforschung vs. MRSA / TBC; Infektionskrankheiten MRSA/TBC; Infektionen sind weltweit Todesursache Nr. 1 in Kliniken; Investor Relations spezielle und individuelle Investmentbeteiligungen; Finanzierungskonzepte einer starken Investorengruppe; BÃ¶rsenlisting fÃ¼r biopharmazeutische Weltneuheiten; Pre-Launch Marketing; Davon werden 100.000 TodesfÃ¤lle offiziell bekanntgegeben; Laut World Health Organisation (WHO) die medizinische Herausforderung des Jahrhunderts > 40.000 TodesfÃ¤lle durch Infektionen allein in deutschen Kliniken per anno.
Name: keywords
Content: VIRIDAX TM; "Phagentherapie" Bakteriophagen vs. MRSA; Bakteriophagen; Pharma Marketing PR Europe , BioPharmaForschungBakteriophagen; Weltneuheit Viridax; Gemeinsamkeit macht stark; BioPharmaForschungBacteriophages - Dortmund, MRSA; Bakteriophagen gegen MRSA ; Klinikkillerkeime MRSA; TBC; Bakteriophagen vs. Stapylococcusaureus; Infektionskrankheiten; Investor Relations; Pre-Launch Marketing ; FÃ¶rderungswÃ¼rdiges, humanitÃ¤res Forschungsprojekt, Weltneuheit Bakteriophagen gegen multiresistente Keime; tÃ¶dliche Krankenhauskeime; http://www.bedarfshaltestelle.de/2009/06/23/mrsa-als-thema/
Name:
Content: MycoGenyx TM

Server / Hosting

IP: 54.246.93.193
Latitude: 53.34
Longitude: -6.26
Country: Ireland
City: Dublin

Rname

ns4.vpweb.com
ns2.vpweb.com
ns3.vpweb.com
mx.pharmamarketingltd.com.cust.b.hostedemail.com

Target

hostmaster.vistaprint.net

HTTP Header Response

HTTP/1.1 200 OK Accept-Ranges: bytes Content-Type: text/html; charset=utf-8 Date: Mon, 05 Sep 2016 02:24:38 GMT Last-Modified: Wed, 29 Jun 2016 15:10:06 GMT P3P: CP="VPRT " Vary: Accept-Encoding Content-Length: 20907 X-Cache: MISS from s_ub9 X-Cache-Lookup: MISS from s_ub9:80 Via: 1.1 s_ub9 (squid/3.5.20) Connection: keep-alive